1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6F27CDE6710CF6CAC8525789B006676E1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-healthcare-market-research-outsourcing-leveraging-exclusive-vendor-partnerships?opendocument
18
19opendocument
203.238.82.77
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Competitive and Business Intelligence » Contracting Vendor/ Outsourcing

Healthcare Market Research Outsourcing: Leveraging Exclusive Vendor Partnerships

ID: 5135


Features:

18 Info Graphics

15 Data Graphics

96 Metrics

10 Narratives

22 Best Practices


Pages/Slides: 49


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Healthcare Market Research Outsourcing: Leveraging Exclusive Vendor Partnerships"

Market research groups in the pharmaceutical and biotech industries heavily rely on external vendors for primary market research to support their internal clients. Like other functions that work with vendors, market research groups often struggle to strike the optimal balance between controlling cost and delivering quality insights.

This benchmarking research study examines vendor management strategies to help bio-pharma market research groups provide support and value that aligns with broader organizational goals and commercial objectives. In particular, this research explores trends and efficiencies in the use of exclusive vendor partnerships.

Market research leaders can use this research to compare their organization’s contracting strategy and vendor usage model with those of their industry peers.


Industries Profiled:
Pharmaceutical; Biotech; Medical Device; Manufacturing; Consumer Products; Diagnostic; Chemical; Health Care


Companies Profiled:
Abbott Laboratories; Alcon Labs; Amgen; AstraZeneca; Baxter; Bayer; Biovail; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Eli Lilly; EMD Serono; Ethicon Endo-Surgery; GlaxoSmithKline; Genzyme; Johnson & Johnson Health Care Systems; Johnson & Johnson Pharmaceuticals; Merck; Novartis; Novo Nordisk; Pfizer; Roche; Sun Pharma; Teva Pharmaceuticals

Study Snapshot

A total of 37 representatives from 26 companies participated in this research. All participating companies belong to the bio-pharmaceutical or medical device industries.

Best Practices, LLC used both field surveys and interviews to complete this study. All participants contributed survey data, while deep-dive interviews were also conducted with ten market research executives leaders to harvest additional key insights.


Key topics include:

  • VENDOR PARTNERSHIP BENCHAMARKS
      Outsourcing Levels
      Number of Vendors Used
      Common Contracting Models
  • EXCLUSIVE VENDOR PARTNERSHIPS
      Usage Patterns and Mapping
      Levels Contracted
      Study Types Contracted
  • MANAGING EXCLUSIVE VENDOR PARTNERSHIPS
      Resources and Account Management
      Collaboration with Marketing Teams
      Penalty and Incentive Systems
      Training
      Employee Engagement
  • PERSPECTIVES FROM COMPANIES NOT USING EXCLUSIVE VENDORS
  • INSIGHTS FROM EXECUTIVE INTERVIEWS

Sample Key Finding

Account management frequently occurs at the market research director level: Exclusive Vendors are most often managed at the account level by a market research director, while a market research manager most often serves as a primary point of contact. Exclusive Vendors also tend to work remotely and only rarely ever interact directly with marketing or brand teams.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.